| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1063-4584(98)80006-X |
| P698 | PubMed publication ID | 9743814 |
| P2093 | author name string | F Ronca | |
| L Palmieri | |||
| G Ronca | |||
| P Panicucci | |||
| P2860 | cites work | Rapid colorimetric assay of β-galactosidase and N-acetyl-β-glucosaminidase in human urine | Q39125860 |
| A rapid sensitive collagenase assay | Q39960461 | ||
| Quantitative analysis of hyaluronate in nanogram amounts | Q42169279 | ||
| Catabolism of low-dose heparin in man | Q66917440 | ||
| Carrageenan foot edema test | Q68032186 | ||
| Sponge implants as models | Q68032189 | ||
| Carrageenan pleurisy | Q68032192 | ||
| Continuous assay for cytolytic activity | Q69760982 | ||
| The chemistry of synovial fluid with special regard to hyaluronic acid | Q75820332 | ||
| P304 | page(s) | 14-21 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Osteoarthritis and Cartilage | Q7107605 |
| P1476 | title | Anti-inflammatory activity of chondroitin sulfate | |
| P478 | volume | 6 Suppl A |
| Q42292745 | A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine. |
| Q41866165 | A versatile pH sensitive chondroitin sulfate-PEG tissue adhesive and hydrogel |
| Q79218992 | American Association of Clinical Endocrinologists Medical Guidelines for the Clinical Use of Dietary Supplements and Nutraceuticals |
| Q37951364 | Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule |
| Q36713886 | Antioxidant activity of chondroitin sulfate |
| Q42204107 | Are We Using Slow-Acting Symptomatic Chondroprotective Drugs Conscious Enough? |
| Q44263350 | Binding of [99mTc]chondroitin sulfate to scavenger receptors on human chondrocytes as compared to binding of oxidized [125I]LDL on human macrophages |
| Q38616606 | Biomimetic collagenous scaffold to tune inflammation by targeting macrophages |
| Q44794590 | Characterization of injectable hydrogels based on poly(N-isopropylacrylamide)-g-chondroitin sulfate with adhesive properties for nucleus pulposus tissue engineering |
| Q42120224 | Chitosan hydrogels for chondroitin sulphate controlled release: an analytical characterization |
| Q41014505 | Chondroitin Lyase from a Marine Arthrobacter sp. MAT3885 for the Production of Chondroitin Sulfate Disaccharides. |
| Q41544409 | Chondroitin Sulfate Inhibits Monocyte Chemoattractant Protein-1 Release From 3T3-L1 Adipocytes: A New Treatment Opportunity for Obesity-Related Inflammation? |
| Q64935652 | Chondroitin Sulphate Attenuates Atherosclerosis in ApoE Knockout Mice Involving Cellular Regulation of the Inflammatory Response. |
| Q36059429 | Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. |
| Q36994144 | Chondroitin sulfate, hyaluronic acid and chitin/chitosan production using marine waste sources: characteristics, applications and eco-friendly processes: a review. |
| Q41866576 | Chondroitin sulphate decreases collagen synthesis in normal and scleroderma fibroblasts through a Smad-independent TGF-beta pathway--implication of C-Krox and Sp1. |
| Q34906145 | Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI |
| Q35196931 | Chondroprotective agents: glucosamine and chondroitin |
| Q33920880 | Dietary supplements as disease-modifying treatments in osteoarthritis: a critical appraisal |
| Q38371965 | Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. |
| Q28354361 | Do glucosamine and chondroitin treat the symptoms of osteoarthritis? |
| Q78467470 | Effect of chondroitin sulfate on murine splenocytes sensitized with ovalbumin |
| Q36736328 | Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis |
| Q89282120 | Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials |
| Q41846829 | Effects of [3H]glucosamine concentration on [3H]chondroitin sulphate formation by cultured chondrocytes |
| Q36713889 | Effects of chondroitin sulfate on the cellular metabolism |
| Q24606203 | Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis |
| Q38362244 | Glucosamine Hydrochloride but Not Chondroitin Sulfate Prevents Cartilage Degradation and Inflammation Induced by Interleukin-1α in Bovine Cartilage Explants |
| Q79319417 | Glucosamine and chondroitin for osteoarthritis: to recommend or not to recommend? |
| Q42330053 | Glucosamine and chondroitin for the treatment of osteoarthritis |
| Q84950953 | High-performance CE of Escherichia coli K4 cell surface polysaccharides |
| Q84230745 | Hydrogels of collagen/chondroitin sulfate/hyaluronan interpenetrating polymer network for cartilage tissue engineering |
| Q44594889 | Immunobiological Effects of Glucosamine In Vitro |
| Q33994668 | Immunological activity of chondroitin sulfate |
| Q37310621 | Immunomodulatory and anti-inflammatory effects of chondroitin sulphate |
| Q57342057 | Insolubilization of sodium chondroitin sulfate by forming a semi-interpenetrating polymer network with acrylic acid: A potential carrier for colon-specific drug delivery |
| Q40626602 | Interleukin-12 release from macrophages by hyaluronan, chondroitin sulfate A and chondroitin sulfate C oligosaccharides |
| Q33995634 | Management of chronic osteoarthritic pain |
| Q51025004 | Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. |
| Q37597619 | Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system |
| Q90439510 | Oral Bioavailability and Pharmacokinetics of Nonanimal Chondroitin Sulfate and Its Constituents in Healthy Male Volunteers |
| Q33631650 | Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes |
| Q34112904 | Pharmacoproteomic study of three different chondroitin sulfate compounds on intracellular and extracellular human chondrocyte proteomes |
| Q36160310 | Preparation of Low Molecular Weight Chondroitin Sulfates, Screening of a High Anti-Complement Capacity of Low Molecular Weight Chondroitin Sulfate and Its Biological Activity Studies in Attenuating Osteoarthritis |
| Q42684285 | Synthesis of Thermogelling Poly(N-isopropylacrylamide)-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering. |
| Q64258807 | The Effects of Glucosamine and Chondroitin Sulfate on Gut Microbial Composition: A Systematic Review of Evidence from Animal and Human Studies |
| Q111459775 | The SARS-CoV-2 Entry Inhibition Mechanisms of Serine Protease Inhibitors, OM-85, Heparin and Soluble HS Might Be Linked to HS Attachment Sites |
| Q53878167 | [Clinical and histopathological improvement of psoriasis in patients with osteoarthritis treated with chondroitin sulfate: report of 3 cases]. |
| Q84599979 | [Effect of chondroitin sulfate and hyaluronic acid (500-730 kDa) on synthesis of stromelysin (MMP-3) and MMP-1 in human chondrocyte cultures] |
Search more.